19 April 2018
Financials: Tying Your Financials to Your Story
We showcase an outstanding team of entrepreneurs who are looking to raise capital for their venture. They have gone through an extensive coaching from our experienced coaches and these founders are eager to present their venture to the entrepreneurial community at this event. They would greatly appreciate your feedback, insights and encouragement. You will also learn a few tips and techniques in sharpening your own pitch for your venture.
Sorin Draghici, Ph.D., Founder and CEO
The company’s mission is to enable a true personalized medicine approach by providing advanced tools that can leverage omics and genomics data to improve drug development and patient care. These technologies, available either as SaaS or concierge services, can be used to improve the success of clinical trials by distinguishing between respondents and non-respondents, design optimal treatments by distinguishing between more and less aggressive types of diseases, repurpose drugs based and predict side-effects.
PANEL DISCUSSION: Tying Your Financials to Your Story
In addition, we have a panel of experts who will guide you through understanding importance of financials in presenting your venture to investors. There are certain things investors are looking for in the financials presented by entrepreneurs in their executive summary or initial investor pitch when they are seeking funding. Although no forecast can be counted on with certainty, investors look for a reasonable business model, expectations of sales growth and cash flow, P&L forecasts, and valid assumptions behind any plan. They also look for red flags: sure signs that the numbers are not to be trusted and that the founding team might need too much help. In this month's forum, we want to focus on what founders can do to use Financials to emphasize their story (Plans behind the Financials) - what they want investors to know to reinforce the Investor Thesis. We are including some founders on our panel to tell us what worked and didn't work from the founder perspective. We hope that this will be of greater interest and value to founders and it will be a dynamic discussion between investors, founders and the audience.
David Gregorka, Venture Partner, Baird Capital
Gregorka is based in Ann Arbor, Mich. and works to source, evaluate, and oversee investment opportunities in the healthcare sector, with a particular emphasis on healthcare IT. Previously, Gregorka co-founded HealthMedia, now called Wellness & Prevention, Inc. (a Johnson & Johnson Company), where he served in multiple roles, including CFO and Operations VP. In prior organizations he served on the executive management teams of a start-up company that developed tools for managing and analyzing large data sets and an international public health and environmental standards and certification organization. An active member of the Michigan entrepreneurial community, Dave serves as a member of the Oversight Committee for the University of Michigan - Michigan Translation and Commercialization for Life Sciences Program (U-M MTRAC), the State of Michigan Advisory Board of Examiners and the advisory boards of several emerging companies. Gregorka received his bachelor’s degree from the University of Rochester, as well as MBA and M.S. degrees from the University of Michigan.
Gerry Roston, CEO, Civionics
Gerry Roston serves as the CEO of Civionics, a University of Michigan startup that delivers intelligent sensor-based systems to manufacturers to help them minimize unplanned downtime; and is an Executive-in-Residence at TechTown Detroit, where he helps entrepreneurs transition their ideas into sustainable businesses.
Colleen Spencer, CFO, Genomenon
Colleen Spencer has an MBA from the University of Michigan’s Ross School and has been a pillar of the Ann Arbor start-up community for over 15 years. She began her career with one of the Big Five accounting firms and has held lead financial positions with several companies before becoming part of the local start-up community. She has held the position of controller at EDF Ventures and CFO positions at several early start-ups, including HandyLab, Tissue Regeneration Systems, and Tangent Medical Technologies. Currently she is CFO at NEF coaching graduate, Genomenon.
Stewart V. (Stew) Nelson, CEO, Mayasil LLC.
If you are active in the entrepreneurial ecosystem in SE Michigan, it is likely that you have met Stew Nelson. Stew is the past President of the New Enterprise Forum. Stew is a serial entrepreneur with Founder’s title in Mayasil, LLC, GAPro Systems, Adrelenventis, LLC, Solidspeed Networks and Geostrip Systems just to mention a few. As an active angel investor, he has ownership equity positions in Blaze Medical Devices, Sentinl, SurClean, Catalyst, Family Mint, among others. Stew is a retired pilot with over 30 years of military and commercial experience and more recently as a commercial insurance professional with Kapnick Insurance Group. Not satisfied with retirement three times now, Stew is currently serving as CEO of Mayasil, LLC. Stew is a proud graduate of the University of Michigan, BA, 69 and Eastern Michigan University, MBA 92.
Mark your calendar. The meeting opens at 5:00 pm with networking and appetizers. Around 5:45 pm, the program portion of the meeting begins with an introduction from our President including upcoming entrepreneurial events and past NEF Showcase Presenter news. The program continues with our featured Showcase Presenter(s) who are graduates of the NEF coaching process. Depending on the month or otherwise noted, the program includes the engaging NEF Pitch Pit or intriguing topic and panel. The program typically finishes at 7:15 pm with more networking afterwards. Please feel welcome to join us.